Anti-PD-1 therapy plus chemotherapy versus anti-PD-1 therapy alone in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia: a multicenter, retrospective studyResearch in context

Anti-PD-1 therapy plus chemotherapy versus anti-PD-1 therapy alone in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia: a multicenter, retrospective studyResearch in context

Summary: Background: Synergistic antitumor effects of immunotherapy and chemotherapy have been demonstrated in several solid tumors. However, this combination strategy has not been addressed in gestational trophoblastic neoplasia (GTN) cases. We therefore compared the safety and therapeutic effect...

Full description

Bibliographic Details
Main Authors: Xiaoyu Wang, Wei Cang, Xiaomei Liu, Yu Cheng, Xirun Wan, Fengzhi Feng, Tong Ren, Jun Zhao, Fang Jiang, Hongyan Cheng, Yu Gu, Lihua Chen, Chen Li, Xiuqin Li, Junjun Yang, Xin Lu, Yang Xiang
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:EClinicalMedicine
Subjects:
PD-1 inhibitors
Gestational trophoblastic neoplasia
Combination therapy
Chemotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537023001517

Internet

http://www.sciencedirect.com/science/article/pii/S2589537023001517

Similar Items